3 weeks Novo’s main Ozempic plant cited for quality lapses by FDAFortune
Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.
XNovo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.
X